Sublingual immunotherapy in children: facts and needs (Q34613104)

3 August 2017

1 reference

title

Sublingual immunotherapy in children: facts and needs (English)

1 reference

3 August 2017

1 reference

2

Cristoforo Incorvaia

1 reference

3 August 2017

4

Franco Frati

1 reference

3 August 2017

5

Francesco Marcucci

1 reference

3 August 2017

1

Gian Luigi Marseglia

1 reference

3 August 2017

Mario La Rosa

3

1 reference

3 August 2017

publication date

23 October 2009

1 reference

Italian Journal of Paediatrics

3 August 2017

published in

1 reference

3 August 2017

volume

35

1 reference

3 August 2017

issue

1

1 reference

3 August 2017

page(s)

31

1 reference

Patient's compliance with allergen immunotherapy

3 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2772839

Sublingual immunotherapy in children: complete and updated review supporting evidence of effect.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2772839

Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2772839

Efficacy and safety of 5-grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2772839

Economic studies of immunotherapy: a review

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2772839

The safety of allergen specific sublingual immunotherapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2772839

Metaanalysis of the efficacy of sublingual immunotherapy in the treatment of allergic asthma in pediatric patients, 3 to 18 years of age.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2772839

Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2772839

The safety of sublingual-swallow immunotherapy: an analysis of published studies

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2772839

Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2772839

Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2772839

Sublingual immunotherapy in asthma and rhinoconjunctivitis; systematic review of paediatric literature

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2772839

Sublingual immunotherapy for allergic rhinitis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2772839

Noninjection routes for immunotherapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2772839

Allergic rhinitis and its impact on asthma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2772839

Systemic reactions and fatalities associated with allergen immunotherapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2772839

Safety of sublingual-swallow immunotherapy in children and adults

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2772839

Clinical guidelines: developing guidelines

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2772839

Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2772839

Cost effectiveness of sublingual immunotherapy in children with allergic rhinitis and asthma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2772839

Post-marketing survey on the safety of sublingual immunotherapy in children below the age of 5 years

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2772839

Efficacy of sublingual allergen vaccination for respiratory allergy in children. Conclusions from one meta-analysis

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2772839

Safety of sublingual immunotherapy started during the pollen season

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2772839

Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children

9 December 2018

1 reference

12 December 2020

Children's compliance with allergen immunotherapy according to administration routes

1 reference

12 December 2020

Comparison between continuous or intermittent schedules of sublingual immunotherapy for house dust mites: effects on compliance, patients satisfaction, quality of life and safety

1 reference

12 December 2020

Quantitative assessment of the compliance with once-daily sublingual immunotherapy in children (EASY project: evaluation of a novel SLIT formulation during a year)

1 reference

12 December 2020

Safety of sublingual-swallow immunotherapy in children aged 3 to 7 years

1 reference

12 December 2020

Anaphylactic reaction after the first dose of sublingual immunotherapy with grass pollen tablet

1 reference

12 December 2020

Dose dependence of immunological response to sublingual immunotherapy

1 reference

12 December 2020

The safety of sublingual immunotherapy with one or multiple pollen allergens in children

1 reference

12 December 2020

Pharmacoeconomic assessment of specific immunotherapy versus current symptomatic treatment for allergic rhinitis and asthma in France

1 reference

12 December 2020

Safety and tolerability of ultra-rush induction, less than one hour, of sublingual immunotherapy in children

1 reference

12 December 2020

Sublingual immunotherapy is not always a safe alternative to subcutaneous immunotherapy

1 reference

12 December 2020

Immunotherapy in children and adolescents with allergic rhinoconjunctivitis: a systematic review

1 reference

12 December 2020

Identifiers

DOI

10.1186/1824-7288-35-31

1 reference

Dimensions Publication ID

3 August 2017

0 references

1 reference

3 August 2017

1 reference